Gain Therapeutics, Inc. (GANX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.9
Day's range
$3.07

Gain Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MARSHALL WACE, LLP 08/13/2026 1.92 M $3.90 M   8.69% 4.49%
POTOMAC CAPITAL MANAGEMENT, INC. 08/14/2026 946.40 K $1.92 M   -6.17% 2.21%
GSA CAPITAL PARTNERS LLP 08/06/2026 632.13 K $1.28 M   102.30% 1.47%
JONES FINANCIAL COMPANIES LLLP 08/14/2026 608.59 K $1.07 M   -3.65% 1.42%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 07/30/2026 568.65 K $1.15 M   0.00% 1.33%
DME CAPITAL MANAGEMENT, LP 08/14/2026 566.13 K $1.15 M   0.00% 1.32%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 480.27 K $974.95 K   20.10% 1.12%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 453.50 K $921.37 K   1.38% 1.06%
BLACKROCK, INC. 08/07/2026 274.96 K $558.16 K   22.18% 0.64%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 231.53 K $470.01 K   0.68% 0.54%
UBS GROUP AG 08/13/2026 215.01 K $436.48 K   -2.48% 0.50%
STRATOS WEALTH PARTNERS, LTD. 08/11/2026 200.00 K $406.00 K   51.95% 0.47%
CRESSET ASSET MANAGEMENT, LLC 08/14/2026 160.00 K $324.80 K   0.00% 0.37%
STATE STREET CORP 09/22/2026 157.54 K $319.80 K   0.00% 0.37%
CITADEL ADVISORS LLC 09/02/2026 154.52 K $313.68 K   520.58% 0.36%
SQUAREPOINT OPS LLC 08/14/2026 136.36 K $276.81 K   100.00% 0.32%
MORGAN STANLEY 08/13/2026 125.97 K $255.72 K   -9.80% 0.29%
LPL FINANCIAL LLC 08/07/2026 117.25 K $238.02 K   12.47% 0.27%
NORTHERN TRUST CORP 08/13/2026 97.01 K $196.94 K   -14.90% 0.23%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 78.21 K $158.76 K   -81.87% 0.18%
COMMONWEALTH EQUITY SERVICES, LLC 07/29/2026 58.46 K $118.67 K   96.80% 0.14%
JANE STREET GROUP, LLC 08/14/2026 55.63 K $112.93 K   -74.35% 0.13%
XTX TOPCO LTD 08/14/2026 55.29 K $112.25 K   100.00% 0.13%
JANE STREET GROUP, LLC 08/14/2026 41.60 K $84.45 K   7.77% 0.10%
CITADEL ADVISORS LLC 09/02/2026 40.70 K $82.62 K   180.69% 0.09%
PRELUDE CAPITAL MANAGEMENT, LLC 08/14/2026 35.82 K $72.72 K   0.00% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 35.70 K $72.47 K   100.00% 0.08%
BENEDICT FINANCIAL ADVISORS INC 07/16/2026 35.00 K $71.05 K   125.81% 0.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 30.00 K $60.91 K   0.00% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 28.90 K $58.67 K   -24.54% 0.07%
APOLLON WEALTH MANAGEMENT, LLC 07/23/2026 26.50 K $53.80 K   0.00% 0.06%
VIRTU FINANCIAL LLC 08/13/2026 21.02 K $43.00 K   96.68% 0.05%
OLIVER LUXXE ASSETS LLC 07/09/2026 20.25 K $41.11 K   0.00% 0.05%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 18.38 K $37.30 K   0.00% 0.04%
HIGHTOWER ADVISORS, LLC 08/05/2026 17.17 K $34.86 K   100.00% 0.04%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 07/15/2026 17.06 K $30.70 K   9.64% 0.04%
WEALTHSPIRE ADVISORS, LLC 08/11/2026 16.90 K $34.31 K   0.00% 0.04%
SANDHILL CAPITAL PARTNERS LLC 08/13/2026 15.40 K $31.26 K   0.00% 0.04%
MILLINGTON FINANCIAL ADVISORS, LLC 08/07/2026 15.00 K $25.65 K   0.00% 0.04%
HB WEALTH MANAGEMENT, LLC 07/29/2026 12.78 K $25.95 K   100.00% 0.03%
TWO SIGMA SECURITIES, LLC 08/14/2026 12.74 K $25.86 K   100.00% 0.03%
HARBOUR INVESTMENTS, INC. 08/12/2026 10.75 K $21.81 K   100.00% 0.03%
NEWEDGE ADVISORS, LLC 08/12/2026 10.60 K $21.52 K   0.00% 0.02%
MERCER GLOBAL ADVISORS INC /ADV 08/19/2026 10.00 K $20.30 K   100.00% 0.02%
SANCTUARY ADVISORS, LLC 08/13/2026 10.00 K $20.30 K   100.00% 0.02%
WELLS FARGO & COMPANY/MN 08/14/2026 9.40 K $19.08 K   -14.93% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 8.32 K $16.89 K   51.13% 0.02%
GROUP ONE TRADING, L.P. 08/14/2026 3.81 K $7.73 K   -40.54% 0.01%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 2.00 K $4.06 K   100.00% 0.00%
SRS CAPITAL ADVISORS, INC. 08/10/2026 1.70 K $3.45 K   100.00% 0.00%

Gain Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 58 institutional investors and hedge funds held shares of Gain Therapeutics Inc. The most heavily invested institutionals were:

MARSHALL WACE, LLP: 1.92 M

Potomac Capital Management, Inc.: 946,400

GSA CAPITAL PARTNERS LLP: 632,131

JONES FINANCIAL COMPANIES LLLP: 608,592

Cambridge Investment Research Advisors, Inc.: 568,645

DME Capital Management, LP: 566,130

20.20% of Gain Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 10.03 M shares in the last 24 months. This purchase volume represents approximately $29.38 M in transactions.